These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Giordano G; Gnetti L; Merisio C; Melpignano M Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204 [TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348 [TBL] [Abstract][Full Text] [Related]
9. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095 [TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer. Ino K; Yoshida N; Kajiyama H; Shibata K; Yamamoto E; Kidokoro K; Takahashi N; Terauchi M; Nawa A; Nomura S; Nagasaka T; Takikawa O; Kikkawa F Br J Cancer; 2006 Dec; 95(11):1555-61. PubMed ID: 17117179 [TBL] [Abstract][Full Text] [Related]
11. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer. Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma. Suthipintawong C; Wejaranayang C; Vipupinyo C J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of WT1 protein in endometrial cancer. Ohno S; Dohi S; Ohno Y; Kyo S; Sugiyama H; Suzuki N; Inoue M Anticancer Res; 2009 May; 29(5):1691-5. PubMed ID: 19443388 [TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy. Graesslin O; Chantot-Bastaraud S; Lorenzato M; Birembaut P; Quéreux C; Daraï E Ann Surg Oncol; 2008 Feb; 15(2):484-92. PubMed ID: 18071824 [TBL] [Abstract][Full Text] [Related]
15. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma. Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605 [TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875 [TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817 [TBL] [Abstract][Full Text] [Related]
18. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725 [TBL] [Abstract][Full Text] [Related]
19. Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer. Steiner E; Pollow K; Hasenclever D; Schormann W; Hermes M; Schmidt M; Puhl A; Brulport M; Bauer A; Petry IB; Koelbl H; Hengstler JG Gynecol Oncol; 2008 Mar; 108(3):569-76. PubMed ID: 18222533 [TBL] [Abstract][Full Text] [Related]
20. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]